The 1 analysts offering 12-month price forecasts for Anixa Biosciences Inc have a median target of 8.50, with a high estimate of 8.50 and a low estimate of 8.50. The median estimate represents a +271.18% increase from the last price of 2.29.
The current consensus among 1 polled investment analysts is to Buy stock in Anixa Biosciences Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date Jun 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.